Caloric restriction leads to high marrow adiposity and low bone mass in growing mice
Our program What is Mochi
In general, and similar to FDA-approved labeling for GLP-1 weight-management medications, you may be considered for a GLP-1 prescription if you: Have a BMI of 30 or higher (obesity), or Have a BMI between 2729.9 (overweight) plus a weight-related health condition Weight-related conditions can include high blood pressure, type 2 diabetes, sleep apnea, high cholesterol, or PCOS (Polycystic Ovary Syndrome), for example
Full Dosing Guide Phase 3 TRIUMPH titration schedules week-by-week for 4, 9, and 12 mg targets Weight loss by dose level Phase 2, TRIUMPH-4, and T2D trial data What to do if you miss a dose How retatrutide dosing compares to tirzepatide and semaglutide Stopping retatrutide and tapering Frequently Asked Questions How many units is 2 mg of retatrutide